CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The project focuses on developing a minimally invasive cardiac implant that effectively isolates the Left Atrial Appendage to reduce stroke risk in patients with Persistent Atrial Fibrillation. This innovative solution aims to improve treatment outcomes while minimizing surgery time.
Atrial Fibrillation (AF) is an irregular heartbeat that can lead to blood clots, high risk of stroke and heart failure. AF is caused by abnormal electrical activity in the heart.
There are 10.7 million AF patients across Europe and the US, 3.6 million are classified as having Persistent AF (PAF).
Surgical treatment for AF is a minimally invasive electrical therapy which destroys heart tissue causing the abnormal electrical pulses.
For PAF patients, this works only 30% of the time.
Approximately…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
